ARP Americas LLC bought a new position in Express Scripts Holding Company (NASDAQ:ESRX) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 3,172 shares of the company’s stock, valued at approximately $203,000.

A number of other institutional investors have also modified their holdings of the company. Meyer Handelman Co. raised its stake in shares of Express Scripts Holding by 1.8% in the first quarter. Meyer Handelman Co. now owns 12,833 shares of the company’s stock valued at $846,000 after buying an additional 233 shares during the last quarter. Dillon & Associates Inc. raised its position in Express Scripts Holding by 5.6% in the first quarter. Dillon & Associates Inc. now owns 6,735 shares of the company’s stock worth $445,000 after buying an additional 355 shares in the last quarter. Oakworth Capital Inc. raised its position in Express Scripts Holding by 7.0% in the first quarter. Oakworth Capital Inc. now owns 2,362 shares of the company’s stock worth $155,000 after buying an additional 155 shares in the last quarter. IFP Advisors Inc raised its position in Express Scripts Holding by 3.1% in the first quarter. IFP Advisors Inc now owns 15,230 shares of the company’s stock worth $1,004,000 after buying an additional 457 shares in the last quarter. Finally, Asset Advisors Corp bought a new position in Express Scripts Holding during the first quarter worth approximately $1,054,000. 88.70% of the stock is currently owned by hedge funds and other institutional investors.

Express Scripts Holding Company (NASDAQ ESRX) opened at 61.53 on Thursday. The stock’s 50 day moving average is $61.89 and its 200-day moving average is $63.95. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.50. The company has a market cap of $35.54 billion, a P/E ratio of 10.68 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.57 EPS. Analysts predict that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.

WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/31/arp-americas-llc-buys-shares-of-3172-express-scripts-holding-company-esrx.html.

A number of research firms recently commented on ESRX. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the company a “buy” rating in a research note on Tuesday. Morgan Stanley lifted their price target on shares of Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a research report on Thursday, August 10th. BidaskClub lowered shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th. Needham & Company LLC started coverage on shares of Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating on the stock. Finally, Cowen and Company restated an “outperform” rating and issued a $83.00 price target on shares of Express Scripts Holding in a research report on Friday, June 9th. Four analysts have rated the stock with a sell rating, thirteen have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $70.03.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of Express Scripts Holding stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the transaction, the vice president now directly owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.68% of the stock is owned by insiders.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.